Security key
45826J105
Intellia Therapeutics, Inc. - Common Stock (NTLA)
CUSIP: 45826J105
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 118,202,207
- Total 13F shares
- 104,167,644
- Share change
- +5,026,180
- Total reported value
- $1,798,715,383
- Put/Call ratio
- 48%
- Price per share
- $17.27
- Number of holders
- 280
- Value change
- +$103,219,618
- Number of buys
- 144
- Number of sells
- 115
Report period
Q3 2025
Institutions
280
Top holders
10
NTLA full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Intellia Therapeutics, Inc. SEC filings
Intellia Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45826J105
Recent filing periods:
Top shareholders of NTLA - Intellia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.2%
from 13D/G
|
10,027,175
|
$94,054,899 | — | 30 Jun 2025 | |
| ARK Investment Management LLC |
13F
|
Company |
11%
|
13,017,876
|
$122,107,675 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.2%
|
10,852,169
|
$101,793,346 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
3.5%
|
4,116,861
|
$38,616,160 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
4,039,285
|
$37,888,493 | — | 30 Jun 2025 | |
| REGENERON PHARMACEUTICALS, INC. |
13F
|
Company |
3.1%
|
3,702,995
|
$34,734,093 | — | 30 Jun 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.3%
|
2,675,674
|
$25,097,822 | — | 30 Jun 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
2.3%
|
2,671,265
|
$25,056,466 | — | 30 Jun 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
2.3%
|
2,671,265
|
$25,003,040 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,606,222
|
$24,448,782 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.9%
|
2,276,574
|
$21,354,264 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.8%
|
2,093,017
|
$19,632,499 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.7%
|
2,047,248
|
$19,203,186 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.6%
|
1,866,309
|
$17,506,968 | — | 30 Jun 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,553,234
|
$14,569,335 | — | 30 Jun 2025 | |
| Contrarius Group Holdings Ltd |
13F
|
Company |
1.3%
|
1,552,508
|
$14,562,525 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
1.3%
|
1,520,548
|
$14,262,742 | — | 30 Jun 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.1%
|
1,311,480
|
$12,301,682 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
1%
|
1,219,068
|
$11,434,858 | — | 30 Jun 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.95%
|
1,127,331
|
$10,574,365 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.8%
|
940,483
|
$8,821,731 | — | 30 Jun 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.77%
|
913,622
|
$8,569,774 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
908,996
|
$8,526,383 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.75%
|
880,873
|
$8,262,588 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.72%
|
856,549
|
$8,034,430 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.7%
|
831,006
|
$7,794,836 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.7%
|
824,727
|
$7,735,939 | — | 30 Jun 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.66%
|
785,034
|
$7,363,647 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.65%
|
763,981
|
$7,166,142 | — | 30 Jun 2025 | |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. |
13F
|
Company |
0.62%
|
729,421
|
$6,841,969 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.6%
|
709,981
|
$6,659,622 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.57%
|
676,900
|
$6,349,322 | — | 30 Jun 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.55%
|
650,000
|
$6,097,000 | — | 30 Jun 2025 | |
| Vestmark Advisory Solutions, Inc. |
13F
|
Company |
0.54%
|
638,342
|
$5,987,648 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.54%
|
637,861
|
$5,983,135 | — | 30 Jun 2025 | |
| Marex Group plc |
13F
|
Company |
0.53%
|
623,600
|
$5,849,368 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.44%
|
518,147
|
$4,860,217 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.43%
|
504,774
|
$4,736,000 | — | 30 Jun 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.39%
|
465,000
|
$4,361,700 | — | 30 Jun 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.39%
|
456,601
|
$4,282,917 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.36%
|
429,148
|
$4,025,408 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.36%
|
426,667
|
$4,002,136 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.35%
|
409,884
|
$3,844,712 | — | 30 Jun 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.34%
|
406,425
|
$3,812,267 | — | 30 Jun 2025 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.31%
|
371,607
|
$3,485,673 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
311,168
|
$2,918,759 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.25%
|
298,711
|
$2,801,909 | — | 30 Jun 2025 | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd |
13F
|
Company |
0.25%
|
294,387
|
$2,761,350 | — | 30 Jun 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.23%
|
267,061
|
$2,505,032 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.21%
|
251,576
|
$2,359,782 | — | 30 Jun 2025 |
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q3 2025
As of 30 Sep 2025,
Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by
280 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
104,167,644 shares.
The largest 10 holders included
ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock, Inc., MORGAN STANLEY, Contrarius Group Holdings Ltd, STATE STREET CORP, GOLDMAN SACHS GROUP INC, REGENERON PHARMACEUTICALS, INC., BAKER BROS. ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
281
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
277
Q3 2025 holders
280
Holder diff
3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.